ALPS has 21 ETFs traded in the U.S. markets with total assets under management of $14.49 B and an average expense ratio of 0.57%.
The largest ALPS ETF is the Alerian MLP ETF (AMLP) with $10.18 B in assets. In the last 12 months, the best performing ALPS ETF was the ALPS Medical Breakthroughs ETF (SBIO) at 34.03%. The most-recent ETF launched by ALPS was the ALPS Clean Energy ETF (ACES) in June 2018.
ALPS offers ETFs in the following asset classes:
There’s a debate over what the 2.0 version of MLPs is supposed to be, according to the CEO of Alerian.
Jeremy Held discusses why MLPs have been getting crushed and whether now is a good time to buy into the space.
Proposed tariffs will, at best, hit pockets of the market rather than spark global recession.
Newer funds take a more customized perspective as impact investing gains attention.
One in six U.S. ETFs has a connection to the marijuana industry.
The greatest ETFs you've never heard of.
The largest ETFs by assets aren't necessarily the most profitable for issuers.
Dividend ETFs barely touched by the corporate stalwart’s 50% dividend cut.
How one expert thinks master limited partnerships will be impacted by the coming tax reform.
